These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10356626)

  • 1. Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold.
    Triggs WJ; McCoy KJ; Greer R; Rossi F; Bowers D; Kortenkamp S; Nadeau SE; Heilman KM; Goodman WK
    Biol Psychiatry; 1999 Jun; 45(11):1440-6. PubMed ID: 10356626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy.
    Nahas Z; Kozel FA; Li X; Anderson B; George MS
    Bipolar Disord; 2003 Feb; 5(1):40-7. PubMed ID: 12656937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial.
    Fabre I; Galinowski A; Oppenheim C; Gallarda T; Meder JF; De Montigny C; Olié JP; Poirier MF
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):833-42. PubMed ID: 15352140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive effects of 1- and 20-hertz repetitive transcranial magnetic stimulation in depression: preliminary report.
    Little JT; Kimbrell TA; Wassermann EM; Grafman J; Figueras S; Dunn RT; Danielson A; Repella J; Huggins T; George MS; Post RM
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):119-24. PubMed ID: 10780630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression.
    Pascual-Leone A; Rubio B; Pallardó F; Catalá MD
    Lancet; 1996 Jul; 348(9022):233-7. PubMed ID: 8684201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-site pilot randomized 3 day trial of high dose left prefrontal repetitive transcranial magnetic stimulation (rTMS) for suicidal inpatients.
    George MS; Raman R; Benedek DM; Pelic CG; Grammer GG; Stokes KT; Schmidt M; Spiegel C; Dealmeida N; Beaver KL; Borckardt JJ; Sun X; Jain S; Stein MB
    Brain Stimul; 2014; 7(3):421-31. PubMed ID: 24731434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation.
    Holtzheimer PE; Russo J; Claypoole KH; Roy-Byrne P; Avery DH
    Depress Anxiety; 2004; 19(1):24-30. PubMed ID: 14978782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical response.
    Pallanti S; Di Rollo A; Antonini S; Cauli G; Hollander E; Quercioli L
    Neuropsychobiology; 2012 Jun; 65(4):227-35. PubMed ID: 22653158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression.
    Loo C; Mitchell P; Sachdev P; McDarmont B; Parker G; Gandevia S
    Am J Psychiatry; 1999 Jun; 156(6):946-8. PubMed ID: 10360138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
    Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant efficacy of high and low frequency rTMS at 110% of motor threshold versus sham stimulation over left prefrontal cortex.
    Speer AM; Wassermann EM; Benson BE; Herscovitch P; Post RM
    Brain Stimul; 2014; 7(1):36-41. PubMed ID: 23928104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients.
    Speer AM; Kimbrell TA; Wassermann EM; D Repella J; Willis MW; Herscovitch P; Post RM
    Biol Psychiatry; 2000 Dec; 48(12):1133-41. PubMed ID: 11137053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
    George MS; Lisanby SH; Avery D; McDonald WM; Durkalski V; Pavlicova M; Anderson B; Nahas Z; Bulow P; Zarkowski P; Holtzheimer PE; Schwartz T; Sackeim HA
    Arch Gen Psychiatry; 2010 May; 67(5):507-16. PubMed ID: 20439832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: an open study.
    Dragasevic N; Potrebić A; Damjanović A; Stefanova E; Kostić VS
    Mov Disord; 2002 May; 17(3):528-32. PubMed ID: 12112202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of adverse cognitive effects of 1 Hz and 20 Hz repetitive transcranial magnetic stimulation at 100% of motor threshold over left prefrontal cortex in depression.
    Speer AM; Repella JD; Figueras S; Demian NK; Kimbrell TA; Wasserman EM; Post RM
    J ECT; 2001 Dec; 17(4):259-63. PubMed ID: 11731727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive safety of dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression.
    Schulze L; Wheeler S; McAndrews MP; Solomon CJ; Giacobbe P; Downar J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1213-26. PubMed ID: 27157074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral blood flow ratio of the dorsolateral prefrontal cortex to the ventromedial prefrontal cortex as a potential predictor of treatment response to transcranial magnetic stimulation in depression.
    Kito S; Hasegawa T; Koga Y
    Brain Stimul; 2012 Oct; 5(4):547-53. PubMed ID: 22019081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression.
    Mogg A; Pluck G; Eranti SV; Landau S; Purvis R; Brown RG; Curtis V; Howard R; Philpot M; McLoughlin DM
    Psychol Med; 2008 Mar; 38(3):323-33. PubMed ID: 17935639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex and cortical excitability in patients with major depressive disorder.
    Bajbouj M; Brakemeier EL; Schubert F; Lang UE; Neu P; Schindowski C; Danker-Hopfe H
    Exp Neurol; 2005 Dec; 196(2):332-8. PubMed ID: 16194530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.